1. Home
  2. VXRT vs GAUZ Comparison

VXRT vs GAUZ Comparison

Compare VXRT & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VXRT
  • GAUZ
  • Stock Information
  • Founded
  • VXRT N/A
  • GAUZ 2009
  • Country
  • VXRT United States
  • GAUZ Israel
  • Employees
  • VXRT N/A
  • GAUZ N/A
  • Industry
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • GAUZ Industrial Machinery/Components
  • Sector
  • VXRT Health Care
  • GAUZ Miscellaneous
  • Exchange
  • VXRT Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • VXRT 200.3M
  • GAUZ 193.8M
  • IPO Year
  • VXRT N/A
  • GAUZ 2024
  • Fundamental
  • Price
  • VXRT $0.76
  • GAUZ $11.51
  • Analyst Decision
  • VXRT Strong Buy
  • GAUZ Strong Buy
  • Analyst Count
  • VXRT 2
  • GAUZ 4
  • Target Price
  • VXRT $3.00
  • GAUZ $16.25
  • AVG Volume (30 Days)
  • VXRT 2.6M
  • GAUZ 71.5K
  • Earning Date
  • VXRT 03-13-2025
  • GAUZ 02-10-2025
  • Dividend Yield
  • VXRT N/A
  • GAUZ N/A
  • EPS Growth
  • VXRT N/A
  • GAUZ N/A
  • EPS
  • VXRT N/A
  • GAUZ N/A
  • Revenue
  • VXRT $16,760,000.00
  • GAUZ $94,346,000.00
  • Revenue This Year
  • VXRT $128.77
  • GAUZ $34.69
  • Revenue Next Year
  • VXRT N/A
  • GAUZ $35.73
  • P/E Ratio
  • VXRT N/A
  • GAUZ N/A
  • Revenue Growth
  • VXRT 303.27
  • GAUZ 29.76
  • 52 Week Low
  • VXRT $0.52
  • GAUZ $6.78
  • 52 Week High
  • VXRT $1.54
  • GAUZ $17.10
  • Technical
  • Relative Strength Index (RSI)
  • VXRT 55.26
  • GAUZ N/A
  • Support Level
  • VXRT $0.70
  • GAUZ N/A
  • Resistance Level
  • VXRT $0.83
  • GAUZ N/A
  • Average True Range (ATR)
  • VXRT 0.09
  • GAUZ 0.00
  • MACD
  • VXRT -0.00
  • GAUZ 0.00
  • Stochastic Oscillator
  • VXRT 36.62
  • GAUZ 0.00

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

Share on Social Networks: